Christopher Ehrlich

Christopher Ehrlich

Director/Board Member bij EFFECTOR THERAPEUTICS, INC.

Vermogen: 2 M $ op 31-03-2024

54 jaar
Health Technology
Finance
Consumer Services

Profiel

Christopher B.
Ehrlich
is the founder of Prostate Management Diagnostics, Inc. (founded in 2014) and holds the title of Director.
He is also the founder of AlgoRx Pharmaceuticals, Inc. Mr. Ehrlich's current jobs include being a Director at QuatRx Pharmaceuticals Co. (since 2004), Prolynx LLC (since 2022), and eFFECTOR Therapeutics, Inc. (since 2021).
He is also the Chief Operating Officer & Director at CERo Therapeutics Holdings, Inc. (since 2021).
Mr. Ehrlich's former jobs include being the Chief Executive Officer & Director at Locust Walk Acquisition Corp.
(2020-2021), Chief Executive Officer & Director at Phoenix Biotech Acquisition Corp., Director-Business Development at Genentech, Inc. (1997), Director at KAI Pharmaceuticals, Inc., Director at BioMimetic Therapeutics, Inc. (2004-2013), Director at Satori Pharmaceuticals, Inc., Director at Carbylan Therapeutics, Inc., Director at Invuity, Inc., Director at Solace Pharmaceuticals, Inc., Director at Xenon Pharmaceuticals, Inc., Director-Licensing & Business Development at Purdue Pharma LP (1998-1999), Director-Biotechnology Strategy Development at The Lek (1992-1994), Managing Director & General Partner at InterWest Partners LLC (2000-2013), Director at CVRx, Inc., Director-Venture Capital at The US Russia Investment Fund (1994-1996), and Director at Follica, Inc. He was also an Independent Director at Transcept Pharma, Inc. (2009-2013) and Senior MD & Head-Global Biopharma at Locust Walk Partners LLC (2013-2021).
Mr. Ehrlich's education includes an undergraduate degree from Dartmouth College (1992) and an MBA from Kellogg School of Management (1998).
Mr. Ehrlich is also the founder of AlgoRx Pharmaceuticals, Inc...

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
3.24%
05-04-2024 482 425 ( 3.24% ) 1 M $ 31-03-2024
29-02-2024 1 409 ( 0.04% ) 20 276 $ 31-03-2024

Actieve functies van Christopher Ehrlich

BedrijvenFunctieBegin
EFFECTOR THERAPEUTICS, INC. Director/Board Member 25-08-2021
Director/Board Member 20-09-2022
Founder 01-01-2014
Director/Board Member 01-10-2004
Alle actieve functies van Christopher Ehrlich

Eerdere bekende functies van Christopher Ehrlich

BedrijvenFunctieEinde
EFFECTOR THERAPEUTICS, INC. Chief Executive Officer 01-08-2021
Corporate Officer/Principal 01-01-2021
INVUITY INC Director/Board Member 01-01-2018
Director/Board Member 31-12-2013
Corporate Officer/Principal 01-01-2013
Ervaring van Christopher Ehrlich in detail bekijken

Opleiding van Christopher Ehrlich

Dartmouth College Undergraduate Degree
Kellogg School of Management Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Christopher Ehrlich in detail bekijken

Connecties

99

Eerstegraads connecties

25

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
XENON PHARMACEUTICALS INC.

Health Technology

CVRX, INC.

Health Technology

EFFECTOR THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Consumer Services

Health Technology

Commercial Services

Commercial Services

Finance

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Christopher Ehrlich